Crohn’s disease (CD) is a chronic inflammatory bowel disorder characterized by transmural inflammation affecting any part of the gastrointestinal tract. While the initial presentation often involves inflammatory activity, disease progression frequently leads to complications such as strictures, fistulas, abscesses, and perforations. Accurate imaging plays a pivotal role in diagnosing these complications, guiding treatment decisions, and monitoring disease evolution. Computed tomography (CT) and magnetic resonance imaging (MRI), particularly CT enterography (CTE) and MR enterography (MRE), are cornerstone modalities in the evaluation of CD due to their ability to visualize the entire intestinal tract and detect both intraluminal and extraintestinal findings.
CTE and MRE offer comparable diagnostic accuracy in identifying active inflammation and structural complications. However, MRE has gained increasing prominence due to its superior soft-tissue contrast resolution, which enhances the differentiation between inflammatory and fibrotic changes in the bowel wall. This distinction is critical, as it directly influences therapeutic strategy—active inflammation typically responds to anti-inflammatory agents, while fibrotic strictures may require endoscopic or surgical intervention. Moreover, MRE avoids ionizing radiation, making it especially advantageous for younger patients who require repeated imaging over time.
Pelvic MRI stands as the gold standard for evaluating perianal disease, offering unparalleled detail of the anal sphincter complex and surrounding structures. It enables precise delineation of fistula tracts, abscesses, and their anatomical relationships with pelvic muscles, which is essential for preoperative planning and predicting postoperative outcomes such as fecal incontinence. The use of T2-weighted fat-suppressed sequences, dynamic contrast-enhanced imaging, and diffusion-weighted imaging (DWI) further enhances the detection of subtle inflammatory changes and early signs of healing or recurrence.
Common complications include inflammatory and fibrotic strictures, entero-enteric and enterocutaneous fistulas, and intra-abdominal abscesses. Inflammatory strictures appear on MRE with mural thickening, layered enhancement, increased T2 signal, and luminal narrowing with pre-stenotic dilatation. Fibrotic strictures, in contrast, show hypointense T2 signal, minimal enhancement, and fixed luminal narrowing without upstream dilation. Entero-enteric fistulas manifest as enhancing tracks connecting adjacent bowel loops, often associated with a “star sign” appearance due to multiple angulated inflamed segments. Enterocutaneous fistulas, though challenging to treat, can be accurately localized with CTE or MRE, aiding in surgical and nutritional management.
Extraintestinal manifestations such as venous thrombosis, sacroiliitis, and anemia also warrant attention. Mesenteric or portal vein thrombosis may present with a “rat-tail” sign or liver infarcts, while sacroiliac involvement appears as bone marrow edema and enhancement on MRI. These findings underscore the importance of a comprehensive imaging approach beyond the bowel itself.555-66-8 Molecular Weight
In pregnant patients, MRI remains the preferred modality due to the absence of radiation exposure.863-61-6 Description Although gadolinium use is cautioned in pregnancy, MRI safely evaluates disease activity and complications such as ileal thickening or abscess formation without risk to the fetus.PMID:30222286
In summary, radiologists play a central role in managing Crohn’s disease through accurate interpretation of CTE and MRE findings. Understanding the imaging features of common and rare complications—including strictures, fistulas, abscesses, and extraintestinal manifestations—enables timely diagnosis, appropriate therapy selection, and improved patient outcomes. As imaging technology continues to evolve, integration of quantitative metrics and functional imaging will further refine the assessment of disease activity and response to treatment.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
